Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSamsung El.gdr Regulatory News (SMSN)

Share Price Information for Samsung El.gdr (SMSN)

Share Price is delayed by 15 minutes
Get Live Data
5,075.00    -515.00 (-9.21%)
Bid:
5,060.00
Ask:
5,065.00
Spread: 5.00 (0.099%)
Market Cap: $1.33t
SMSN Live PriceLast checked at - London Stock Exchange

Intraday Samsung El.gdr Share Chart

  • This share is an international stock.

Decision on Share Repurchase Plan

18 Nov 2024 09:22

RNS Number : 6098M
Samsung Electronics Co. Ld
18 November 2024
 

 

Samsung Electronics Co., Ltd. (KS005930, KS005935, SMSN, SMSD), on November 15, 2024, announced that its Board of Directors authorized the following Share Repurchase Plan and Decision on Share Repurchase.

 

Share Repurchase Plan

 

1. Title

Share Repurchase Plan

2. Contents

- Total amount : 10 trillion Korean won

- Method : Installment purchase within a year

- Purpose : To increase shareholders value, etc.

3. Information Release

- Provider : IR Team

- Recipients : Investors, media, etc

- Date of release : November 15, 2024

4. Contact Point

IR Team (Phone: 02-2255-9000)

 

 

 

Decision on Share Repurchase

 

 

1. Number of shares to be repurchased

Common

50,144,628

Other

6,912,036

2. Value of shares to be repurchased(Korean won)

Common

2,682,737,598,000

Other

317,262,452,400

3. Expected Period

Start date

November 18, 2024

End date

February 17, 2025

4. Purpose of repurchase

To increase shareholders value, etc.

5. Method of repurchase

Open market

6. Consignment investment brokers

Samsung Securities Co., Ltd.

Korea Investment & Securities Co, Ltd.

Mirae Asset Securities Co., Ltd.

Shinhan Securities Co., Ltd.

KB Securities Co., Ltd.

7. Date of board resolution (confirmation date)

 November 15, 2024

- Attendance of independent directors at the board of directors meeting

Present

6

Absent

0

- Attendance of auditors who are not

 Independent Directors

0

8. Daily order quantity limit

Common

6,525,123

Other

691,203

 

9. Other Information to Consider:

- Shares denoted as Other are preferred shares.

- In Item 2 above, the value of shares to be repurchased is based on the closing price on the

 day of the board resolution (November 15, 2024). The actual amount may change

 depending on future stock price fluctuations.

  KRW 53,500 per common share and KRW 45,900 per preferred share

- In Items 4 and 5 above, all repurchased shares are planned to be cancelled.

- In Item 7 above, all Audit Committee members are Independent Directors.

- The calculation method for Item 8 above is the smaller of: [] and [the larger of and ].

  10% of the number of shares to be repurchased: 5,014,462 common; 691,203 preferred

  25% of average daily transaction volume for one month ending the day before the date of the

board resolution: 6,525,123 common; 406,507 preferred

  1% of total number of issued shares: 59,697,825 common; 8,228,867 preferred

- No shares were repurchased prior to the decision to repurchase shares.

- Limit on the amount of repurchased shares (Korean won)

1. Limits to Dividendable profit under Commercial Act as of end-2023

215,847,546,502,476

2. Amount of repurchased shares since end-2023

0

3. Amount of dividends on profits and reserves for related profits decided at a general meeting of shareholders since end-2023

2,452,976,485,950

4. The interim dividend amount and related profit reserves decided by the board of directors since end-2023

7,356,460,797,750

Limit on the amount of repurchased shares

(1-2-3-4)

206,038,109,218,776

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCQKFBBCBDKKDD
Date   Source Headline
31st Oct 20249:02 amRNSDelisting and Listing of Stocks
31st Oct 20247:00 amRNSAnnouncement of Capex Plan for FY2024
31st Oct 20247:00 amRNS2024 3Q Earnings Release
31st Oct 20247:00 amRNSQuarterly Dividend for Third Quarter 2024
8th Oct 20247:00 amRNSNotice of 3Q 2024 Earning Release
8th Oct 20247:00 amRNS3Q 2024 Pre-Earnings Guidance
30th Aug 202410:52 amRNS2024 Half-year Business Report
31st Jul 20249:33 amRNSTransaction with Affiliate Company
31st Jul 20249:26 amRNSCharitable Contribution
31st Jul 20247:00 amRNS2024 2Q Earnings Release
31st Jul 20247:00 amRNSQuarterly Dividend for Second Quarter 2024
5th Jul 20247:55 amRNSNotice of 2Q 2024 Earnings Release Schedule
5th Jul 20247:45 amRNS2Q 2024 Pre-Earnings Guidance
28th Jun 20248:53 amRNSSustainability Report 2024
31st May 202410:23 amRNSCorporate Governance Report FY2023
31st May 20247:00 amRNS2024 1Q INTERIM BUSINESS REPORT
21st May 20249:34 amRNSNotice on Change of CEO
30th Apr 20248:10 amRNSTransactions with Affiliated Companies
30th Apr 20247:00 amRNS2024 1Q Earnings Release
30th Apr 20247:00 amRNSQuarterly Dividend for First Quarter 2024
30th Apr 20247:00 amRNS2023 Business Report
5th Apr 20247:11 amRNSNotice of 1Q 2024 Earnings Release Schedule
5th Apr 20247:00 amRNS1Q 2024 Pre-Earnings Guidance
20th Mar 20249:07 amRNSTransactions with Affiliated Companies
20th Mar 20249:05 amRNSResults of the 55th Annual General Meeting
21st Feb 20247:00 amRNSReference Material for 2024 AGM
20th Feb 20248:31 amRNSCharitable Contribution
19th Feb 20249:40 amRNS2023 Separate Financial Statements
19th Feb 20249:34 amRNS2023 Consolidated Financial Statements
31st Jan 20247:00 amRNSYear-End Dividend for FY2023
31st Jan 20247:00 amRNS2023 4Q Earning Release
31st Jan 20247:00 amRNSAnnouncement of Capex Result for FY2023
31st Jan 20247:00 amRNSTransactions with Affiliated Companies
31st Jan 20247:00 amRNSShareholder Return Program for FY2024-2026
9th Jan 20247:00 amRNSNotice of 4Q 2023 Earning Release
9th Jan 20247:00 amRNS4Q 2023 Pre-Earnings Guidance
1st Dec 202311:09 amRNSCharitable Contribution
30th Nov 20237:54 amRNSTransactions with Affiliated Companies
30th Nov 20237:34 amRNS2023 3Q Interim Business Report
6th Nov 20238:43 amRNSAnnouncement of Investor Relations Event
31st Oct 20237:21 amRNSTransactions with Affiliated Companies
31st Oct 20237:18 amRNSAnnouncement of Capex Plan for FY2023
31st Oct 20237:13 amRNSQuarterly Dividend for Third Quarter 2023
31st Oct 20237:10 amRNS2023 3Q Earning Release
11th Oct 20237:10 amRNSNotice of 3Q 2023 Earning Release
11th Oct 20237:04 amRNS3Q 2023 Pre-Earnings Guidance
21st Sep 20237:30 amRNS2022 Business Report
21st Sep 20237:29 amRNS2022 Separate Financial Statements
21st Sep 20237:29 amRNS2022 Consolidated Financial Statements
31st Aug 20238:15 amRNS2023 Half-year Business Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.